Effects of Physical and Psychosocial Stress on Functional Hypothalamic Amenorrhea in Exercising Women
Launched by UNIVERSITY OF COLORADO, COLORADO SPRINGS · Jul 21, 2023
Trial Information
Current as of June 28, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how physical exercise and stress from everyday life might affect menstrual cycle irregularities in women who run or cycle regularly. Specifically, the researchers want to find out if changes in exercise routines or levels of stress can alter hormone levels that are important for menstruation and how long the menstrual cycle lasts.
Women between the ages of 18 and 35 who exercise at least four days a week and have regular menstrual cycles may be eligible to participate. During the study, participants will keep track of their exercise, stress levels, and diet while providing urine and saliva samples. They will be divided into different groups: one group will maintain their usual exercise, while others will either increase their running or cycling, engage in stressful mental tasks, or do both. The researchers will compare the results across these groups to see how hormones and menstrual cycles are affected. If you’re interested, it’s important to note that participants should not have any major health issues or have used hormonal birth control in the last six months.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • participates in structured running or cycling exercise for at least 30 minutes on 4 days per week or more
- • have regular periods every 21 to 35 days
- • have not used hormonal contraceptives for at least the past 6 months
- • are not currently or trying to become pregnant or are breastfeeding, and have not been pregnant or breastfeeding for the past 12 months
- • have never been diagnosed with a menstrual cycle disorder (e.g., menorrhagia, amenorrhea, dysmenorrhea, polycystic ovary syndrome \[PCOS\], endometriosis, premenstrual dysphoric disorder \[PMDD\], menstrual migraines, ovarian cancer, ovarian insufficiency, uterine or endometrial cancer)
- • have never been diagnosed with a metabolic disease (e.g., hypothyroidism, hyperthyroidism, Cushing disease, Addison's disease, diabetes)
- Exclusion Criteria:
- • missing \> 4 consecutive days of aerobic exercise (i.e., running, cycling, cross training) if assigned to the exercise intervention groups
- • they indicate they "Could not participate at all due to a health problem" or have had to modify their exercise training, felt their injury, illness, or other health problem has affected their exercise performance, or experienced symptoms/ health complaints greater than "To a minor extent" on the Oslo Sports Trauma Research Center Questionnaire (exercise training intervention group)
- • demonstrate clinical low energy availability as defined as energy availability \<30 Kcal/kg fat free mass in the first two months of at-home monitoring
- • report menstrual cycle lengths \<21 days or \>35 days in the first two months of at-home monitoring
- • do not demonstrate an anticipated rise in progesterone levels during the latter half of their cycle and luteinizing hormone levels at mid-cycle compared to tests taken during the first few days after menses in the first two months of at-home monitoring
- • begin taking a hormonal contraceptive
- • become pregnant
- • are diagnosed with a menstrual cycle disorder (e.g., menorrhagia, amenorrhea, dysmenorrhea, polycystic ovary syndrome \[PCOS\], endometriosis, premenstrual dysphoric disorder \[PMDD\], menstrual migraines, ovarian cancer, ovarian insufficiency, uterine or endometrial cancer)
- • are diagnosed with a metabolic disease (e.g., hypothyroidism, hyperthyroidism, Cushing disease, Addison's disease, diabetes), 10) are diagnosed with a major cardiovascular disease, respiratory disease, or musculoskeletal injury
- • are unable to follow instructions for any of the procedures
About University Of Colorado, Colorado Springs
The University of Colorado Colorado Springs (UCCS) is a leading academic institution dedicated to advancing research and education in various fields, including healthcare and clinical sciences. As a clinical trial sponsor, UCCS leverages its robust academic resources and interdisciplinary expertise to facilitate innovative research initiatives aimed at improving patient outcomes and advancing medical knowledge. The university's commitment to ethical research practices and collaboration with healthcare professionals positions it as a key contributor to the development of effective therapeutic interventions and public health solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Colorado Springs, Colorado, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported